Colestipol: Clinical Trials

2 trials of Colestipol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 31Completed 1

Follow Colestipol: new trials by email Literature Review of Colestipol trials Research Report on Colestipol

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Neratinib, Loperamide, Colestipol - Early Stage HER2+ Breast Cancer
Phase 2CompletedPuma Biotechnology, Inc.5632015-02-012022-05-06
Sorbent Therapy of the Cutaneous Porphyrias
Colestipol - Erythropoietic Protoporphyria
Phase 2 / Phase 3CompletedBrigham and Women's Hospital42011-05-012017-04-25

Conditions studied

Breast Neoplasms (1)  ·  Protoporphyria, Erythropoietic (1)

Sponsors

Brigham and Women's Hospital (1)  ·  Puma Biotechnology, Inc. (1)

Countries

United States (2)  ·  Australia (1)  ·  Austria (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Spain (1)

Results publications

PMID 32464281, PMID 36702070

NIH funding

2015 (1)